AMERIGEN PHARMACEUTICALS Trademark

Trademark Overview

On Monday, December 28, 2015, a trademark application was filed for AMERIGEN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AMERIGEN PHARMACEUTICALS trademark a serial number of 86858716. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 24, 2026. This trademark is owned by Amerigen Pharmaceuticals, Ltd.. The AMERIGEN PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of hypertension, cardiovascular disease, neurological disorders, attention-deficit hyperactivity disorder, Parkinson's disease, oncology, metabolic disorders, Gaucher's disease and Wilson's disease
amerigen pharmaceuticals

General Information

Serial Number86858716
Word MarkAMERIGEN PHARMACEUTICALS
Filing DateMonday, December 28, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 24, 2026
Registration Number5880320
Registration DateTuesday, October 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of hypertension, cardiovascular disease, neurological disorders, attention-deficit hyperactivity disorder, Parkinson's disease, oncology, metabolic disorders, Gaucher's disease and Wilson's disease
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 24, 2026
Primary Code005
First Use Anywhere DateWednesday, March 12, 2014
First Use In Commerce DateWednesday, March 12, 2014

Trademark Owner History

Party NameAmerigen Pharmaceuticals, Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY
Party NameAmerigen Pharmaceuticals, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY
Party NameAmerigen Pharmaceuticals, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY

Trademark Events

Event DateEvent Description
Thursday, December 31, 2015NEW APPLICATION ENTERED
Wednesday, January 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 13, 2016ASSIGNED TO EXAMINER
Tuesday, April 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2016PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016SOU EXTENSION 1 FILED
Tuesday, July 19, 2016SOU EXTENSION 1 GRANTED
Thursday, July 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2017SOU EXTENSION 2 FILED
Monday, July 17, 2017SOU EXTENSION 2 GRANTED
Wednesday, July 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2018SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2018SOU EXTENSION 3 FILED
Friday, January 5, 2018SOU EXTENSION 3 GRANTED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 29, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018SOU EXTENSION 4 FILED
Tuesday, May 29, 2018SOU EXTENSION 4 GRANTED
Thursday, May 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Thursday, December 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 12, 2018SOU EXTENSION 5 FILED
Thursday, December 20, 2018SOU EXTENSION 5 GRANTED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 12, 2019TEAS STATEMENT OF USE RECEIVED
Friday, July 12, 2019USE AMENDMENT FILED
Wednesday, August 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 5, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 6, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 22, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, September 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 3, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, September 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 24, 2026CANCELLED SEC. 8 (6-YR)

Related Keywords

pharmaceuticals amerigen disease disorders parkinson disorder hyperactivity oncology metabolic wilson gaucher deficit